Skip to main content

Table 8 Predicted Drug-likeness properties of the designed compounds

From: Chemo-informatics activity prediction, ligand based drug design, Molecular docking and pharmacokinetics studies of some series of 4, 6-diaryl-2-pyrimidinamine derivatives as anti-cancer agents

S/NO MW HBD HBA WlogP Lipinski violation Bio availability score Drug likeness
N1 582.69 3 7 4.65 1 0.55 YES
N2 581.70 3 7 5.71 1 0.55 YES
N3 582.69 3 7 4.65 1 0.55 YES
N4 569.65 3 8 4.59 1 0.55 YES
N5 634.52 3 8 5.05 1 0.55 YES